GUIDELINES FOR ABSTRACT SUBMISSION

PLEASE READ CAREFULLY

Maximum care should be given to writing your abstract. Please read carefully the following guidelines, designed to standardize the abstract submission procedure. Abstracts that do not meet these criteria will not be accepted.

ABSTRACT PREPARATION

Format

Studies in all areas of Plastic Surgery Research – basic science and translational science will be considered suitable for presentation: all types of cell therapies, nanotechnology, tissue engineering and regenerative medicine, stem cell biology, adipose tissue and fat grafting, scars, microsurgery, breast, lymphedema, virtual reality and 3D medical printing, wound healing, composite tissue allografts, skin oncology, immunology, and peripheral nerves, and other interesting ideas for the development of plastic surgery.

To achieve a balanced final program, papers will be divided into categories. The purpose of the investigation should be clearly stated, and results must be supplied.

Abstracts should be uniformly written giving a title and using the following headings for the body text:

  1. Introduction
  2. Materials/Patients and Methods
  3. Results
  4. Conclusion

Names, addresses, institutions must not appear in the text, penalty the exclusion.

Maximum length 300 words.

Example

Title:PERIPHERAL NERVE REPAIR: MULTIMODAL COMPARISON OF REGENERATIVE POTENTIAL OF ADIPOSE DERIVED CELLS IN A BIODEGRADABLE CONDUIT

INTRODUCTION
Tissue engineering is a popular topic in peripheral nerve repair. Combining a nerve conduit with supporting cells appears to offer an opportunity for improved clinical outcomes, which have been poor to date. e aim of this study was to provide a broad overview over the most interesting and promising transplantable cells under equal experimental conditions over a long term period.

MATERIALS AND METHODS
1 Mio. of each of the following cell types were introduced into biodegradable fibrin conduits: rat adipose-derived stem cells (rASCs), Schwann cell (SC)-like differentiated rASC (drASC), rat SCs (rSCs), human (h-)ASCs from the superficial and deep abdominal layer as well as human stromal vascular fraction (SVF). e sciatic nerve injury model was used creating a 10mm gap in the le nerve of female Sprague Dawley rats (7 groups of 7 animals, 8 weeks old) and was bridged through this conduit. As a control we re-sutured a 10mm cut nerve segment backwards as an autograph. Long-term evaluation was carried out after 12 weeks in a multimodal manner comprising walking track and morphometric, as well as MRI analysis. e Sciatic Function Index (SFI) was calculated with the help of a functional evaluation tool. Moreover, cross-sections of the nerve proximal, distal and in between the two sutures, corresponding to the former gap, were analyzed. Furthermore gastrocnemius muscle weights between groups were compared and in addition imaging analysis (MRI) was performed.

RESULTS
MRI revealed muscle atrophy across all groups and proved biodegradation of the fibrin conduit. Correlating trends throughout the different evaluation techniques could be shown: Superficial human ASC supported regeneration better than deep, in line with published in vitro data. SC-like drASC had the best regeneration potential when compared to the other adipose tissue derived cells.

CONCLUSIONS
We compared the most interesting transplantable cells in peripheral nerve repair, analyzing them in a multimodal manner comprising functional and morphometric, as well as MRI analysis. In conclusion, particularly differentiated ASCs could be a clinically translatable route towards new methods to enhance peripheral nerve repair.

SUBMISSION INSTRUCTIONS

Submitters

Abstract submission is open to all plastic Surgeons, young residents in training of Plastic Surgery and fellow researchers.

Language and Format

Abstracts must be submitted in English, correctly spelled and carefully checked. Text must be single-spaced, and not exceed 300 words. If accepted for presentation, the original text of the submitted abstract will be printed without any changes or corrections in the final abstract book.

Submission

Abstracts must be submitted online via the ERC website by 20.02.2020.

ACCEPTANCE POLICY

Review

After submission, the ERC Committee will perform an anonymous evaluation and review of the abstracts. Emphasis in the review process will be put on the originality and innovativeness, the scientific use or translational clinical use, following by the quality of the research, the analysis of the data, and the well documented and structured abstract.

Abstracts that meet the requirements are accepted for presentation at the Annual ERC Meeting. Information regarding acceptance/refusal of the abstracts will be issued by April 2020.

Accepted Abstracts

The person whose name appears as “first author” will be presenting the submitted abstract. Onsite substitution of absent first authors by co-authors, or other participants to the meeting, will not be possible.

Multiple Submissions

EURAPS RC website accepts up to two (n=2) abstracts per first author, however in case both abstracts pass review and make it to the final program, the author will choose one of the two abstracts. The second abstract will be automatically presented by the next co-author available. Attempts of submission after 2 abstracts will be rejected.

ETHICS

EURAPS RC has a strict policy against plagiarism, and has implemented software that verifies authenticity and originality of papers. Multiple submissions of the same abstracts with different authors, different titles, in different categories, submission of abstracts with similar texts, are strictly forbidden and will be immediately identified and lead to complete exclusion of the abstract(s) from further evaluation and complete exclusion of the author(s) from future ERC Meetings.

In accordance with EURAPS by-laws, authors are requested to be sensitive to, and show respect for, ethnic, cultural, religious, and gender diversity.

PRESENTATION

Format

For the 9th ERC annual meeting, authors of accepted abstracts are asked to submit their presentation in powerpoint or keynote format, the slide center at least two hours prior to their session. The use of personal computers/mac is not permitted.

In case of any videos embedded within the presentations, authors are requested to bring the original source files in addition to their presentation. The slides should be prepared in 16:9 format, and ERC recommends the use of the international system of units (si) as the official measurement system.

Authors are invited to come to the preview as soon as they arrive, to check the functioning of the presentation and videos upfront, and avoiding unnecessary time pressure.

Time

This year we will have two types of presentations. The reviewing committee will decide which type of presentation the accepted abstract is suited for. The presentation will have either the classical scientific type with allocated time for presentation following of discussion, or the ERC Talk, which will explore a fast lane type of communicating in science, using just 2-3 slides – prepared as a visual abstract – within 4 minutes. Time of presentations and discussion will be announced at the final program. Speakers must adhere to the given minutes, as the presentation will be stopped as soon as the time is up.

Schedule

A preliminary program will be issued prior to the Annual Meeting. Authors can check the ERC website at this time to view the date and time of their presentation.